Clinical Trial

To Collect Enriched Human Serum Following Hydrolyzed Collagen Intake

Completed
View on ClinicalTrials.gov →
Summary
This randomized, double-blind, monocentric, five-way cross-over study aims to collect human serum and plasma samples at 1 and 2 hours after ingestion of hydrolyzed collagen peptides. The enriched sera will be used for ex vivo/ in vitro experiments on skin keratinocytes, fibroblasts, and other cell types to explore the beneficial effects of bioactive collagen peptides. Blood will also be analyzed for amino acid profiles and collagen-derived peptides.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-19; most recent amendment 2026-01-16.
Status change: Recruiting → Completed 2026-01-16
Status change: Not Yet Recruiting → Recruiting 2025-12-03
Trial Details
NCT Number NCT07195396
Lead Sponsor Rousselot BVBA
Collaborators: BioTeSys GmbH
Conditions Healthy Women
Enrollment 3 participants
Start Date 2025-10-22
Primary Completion 2025-12-22 (estimated)
Study Completion 2025-12-22 (estimated)
Updated on ClinicalTrials.gov 2026-01-20